Pancreatic Cancer Research

ResearcherFudan UniversityActive in the last 2 years

Qiongzhu Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2433-7199; OpenAlex author ID A5013472148, A5125255367. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 4 papers

Papers 13

  1. Tumor cell-derived HSP47 promotes pancreatic Cancer metastasis via Homotrimeric collagen-mediated M2 macrophage polarization. Last author DOI 10.1016/j.cellsig.2026.112589↗
  2. LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. Co-author DOI 10.1038/s41419-026-09075-4↗
  3. Mitophagy in pancreatic cancer: mechanistic insights and implications for novel therapeutic strategies. Co-author DOI 10.1038/s41420-026-02948-9↗
  4. Disruption of ACTG1 potentiates anti-TIM-3 immunotherapy by reprogramming the immunosuppressive microenvironment via the CSF3/CSF3R axis in pancreatic cancer. Last author DOI 10.3389/fimmu.2026.1820470↗
  5. Early Diagnosis and Prognosis Prediction of Pancreatic Cancer Using Engineered Hybrid Core-Shells in Laser Desorption/Ionization Mass Spectrometry. Co-author DOI 10.1002/adma.202311431↗
  6. Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression. Last author DOI 10.1016/j.celrep.2023.112666↗
  7. Single-cell mapping reveals several immune subsets associated with liver metastasis of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.medj.2023.07.010↗
  8. Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma. Co-author DOI 10.21037/atm-22-407↗
  9. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Last author DOI 10.1038/s41392-021-00659-4↗
  10. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer. Last author DOI 10.1038/s41392-020-0146-6↗
  11. Inflammatory IFIT3 renders chemotherapy resistance by regulating post-translational modification of VDAC2 in pancreatic cancer. Co-author DOI 10.7150/thno.43093↗
  12. A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fonc.2019.01160↗
  13. A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/ijbs.32899↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christiane J. Bruns · 8 shared papers, 2019–2026 · strength 1.15
  2. Yue Zhao · 8 shared papers, 2019–2026 · strength 1.15
  3. Beiyuan Hu · 6 shared papers, 2020–2024 · strength 0.82
  4. Zhefang Wang · 4 shared papers, 2020–2026 · strength 0.77
  5. Yan Zheng · 5 shared papers, 2019–2023 · strength 0.57
  6. Xinxin Ling · 2 shared papers, 2026 · strength 0.53
  7. Felix Popp · 3 shared papers, 2019–2026 · strength 0.49
  8. Feng Yang · 4 shared papers, 2019–2023 · strength 0.41
  9. Deliang Fu · 4 shared papers, 2019–2023 · strength 0.41
  10. Jiangang Zhao · 2 shared papers, 2020–2026 · strength 0.35
  11. Shun Wang · 2 shared papers, 2021–2026 · strength 0.35
  12. Jiang Long · 2 shared papers, 2022–2024 · strength 0.32
  13. Zijin Xu · 1 shared paper, 2026 · strength 0.29
  14. Alexander Quaas · 1 shared paper, 2026 · strength 0.25
  15. Maximilian Reichert · 1 shared paper, 2026 · strength 0.25
  16. Hana Algül · 1 shared paper, 2026 · strength 0.25
  17. Le Zhu · 1 shared paper, 2026 · strength 0.24
  18. Bo Kong · 2 shared papers, 2020–2021 · strength 0.21
  19. Juxiang Zhang · 1 shared paper, 2024 · strength 0.17
  20. Kun Qian · 1 shared paper, 2024 · strength 0.17
  21. Jiuliang Yan · 1 shared paper, 2022 · strength 0.15
  22. Chuntao Wu · 1 shared paper, 2022 · strength 0.15
  23. Haitao Gu · 1 shared paper, 2022 · strength 0.15
  24. Ning Ren · 2 shared papers, 2019 · strength 0.15
  25. Chenhao Zhou · 2 shared papers, 2019 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.